Showing results (51-60 of 500) with videos related to
Sort By:
Pageof 50
Cancer Immunology Research|December 5, 2018
The Balancing Act between Cancer Immunity and Autoimmunity in Response to ImmunotherapyArabella Young, Zoe Quandt, Jeffrey A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|July 12, 2011
Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cellsCristina Penaranda, Qizhi Tang, Jeffrey A BluestoneAJNR. American Journal of Neuroradiology|September 24, 2011
The CT appearance of a corneal melt: report of 2 casesA Bluestone, J Ackert, P M SomThe Journal of Rheumatology. Supplement|April 1, 1992
The T cell receptor in autoimmune diseasesJ A Bluestone, C Spencer, R HirschImmunity|May 21, 2015
IL-2: Change Structure … Change FunctionJeffrey A Bluestone, Natasha Crellin, Eleonora TrottaExpert Opinion on Therapeutic Targets|April 18, 2015
The therapeutic potential of regulatory T cells for the treatment of autoimmune diseaseJeffrey A Bluestone, Eleonora Trotta, Daqi XuImmunological Reviews|November 28, 2001
Suppressor T cells--they're back and critical for regulation of autoimmunity!L Chatenoud, B Salomon, J A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|January 8, 2013
The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetesMelanie Stumpf, Xuyu Zhou, Jeffrey A BluestoneFrontiers in Immunology|August 23, 2013
Peripherally induced tregs - role in immune homeostasis and autoimmunityMahesh Yadav, Stephen Stephan, Jeffrey A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|May 20, 1998
Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsetsJ A Smith, Q Tang, J A BluestonePageof 50